2020年

論文

英文

  1. Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis.
    Yamana H, Kato K, Kobara H, Fujihara S, Fujita K, Namima D, Fujita N, Kobayashi K, Kamada H, Morishita A, Tsutsui K, Iwama H, Masaki T.
    Anticancer Res 40(1): 121-132, 2020
  2. Efficacy of crystal violet for identifying the distal end in esophageal submucosal tunnel resection.
    Kobara H, Nishiyama N, Mori H, Fujihara S, Shi T, Kozuka K, Chiyo T, Kobayashi N, Fujita K, Tani J, Yachida T, Tsutsui K, Okano K, Suzuki Y, Masaki T.
    Minim Invasive Ther Allied Technol 31: 1-6, 2020
  3. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A, Fujita K, Iwama H, Chiyo T, Fujihara S, Oura K, Tadokoro T, Mimura S, Nomura T, Tani J, Yoneyama H, Kobayashi K, Kamada H, Guan Y, Nishiyama A, Okano K, Suzuki Y, Himoto T, Shimotohno K, Masaki T.
    Am J Physiol Gastrointest Liver Physiol 318(3): G401-G409 , 2020
  4. Outcomes of Endoscopic Submucosal Dissection for Subepithelial Lesions Localized Within the Submucosa, Including Neuroendocrine Tumors: A Multicenter Prospective Study.
    Kobara H, Miyaoka Y, Ikeda Y, Yamada T, Takata M, Fujihara S, Nishiyama N, Fujita K, Tani J, Kobayashi N, Chiyo T, Yachida T, Okano K, Suzuki Y, Mori H, Masaki T.
    J Gastrointestin Liver Dis 29(1): 41-49, 2020
  5. Simple scoring system for prediction of hepatocellular carcinoma occurrence after hepatitis C virus eradication by direct-acting antiviral treatment: All Kagawa Liver Disease Group Study.
    Tani J, Morishita A, Sakamoto T, Takuma K, Nakahara M, Fujita K, Oura K, Tadokoro T, Mimura S, Nomura T, Yoneyama H, Kobara H, Himoto T, Tsutsui A, Senoh T, Nagano T, Ogawa C, Moriya A, Deguchi A, Takaguchi K, Masaki T.
    Oncol Lett 19(3): 2205-2212, 2020
  6. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest.
    Yamashita T, Kato K, Fujihara S, Iwama H, Morishita A, Yamana H, Kobayashi K, Kamada H, Chiyo T, Kobara H, Tsutsui K, Okano K, Suzuki Y, Masaki T.
    Anticancer Drugs 31(3): 231-240, 2020
  7. Association of a Disrupted Dipping Pattern of Blood Pressure with Progression of Renal Injury during the Development of Salt-Dependent Hypertension in Rats.
    Sufiun A, Rahman A, Rafiq K, Fujisawa Y, Nakano D, Kobara H, Masaki T, Nishiyama A.
    Int J Mol Sci 21(6): E2248, 2020
  8. The angiotensin II receptor-neprilysin inhibitor LCZ696 attenuates the progression of proteinuria in type 2 diabetic rats.
    Rahman A, Sherajee SJ, Rafiq K, Kobara H, Masaki T, Nakano D, Morikawa T, Konishi Y, Imanishi M, Nishiyama A.
    J Pharmacol Sci 142(3): 124-126, 2020
  9. Strategy of small-caliber endoscopic submucosal dissection for esophageal neoplasia distal to severe stricture.
    Nishiyama N, Kobara H, Yachida T, Mori H, Shi T, Okano K, Masaki T.
    Endoscopy 52(3): E94-E95, 2020
  10. Does reflux oesophagitis really decrease the quality of life?
    Kinekawa F, Kagawa A, Kita Y, Okura R, Nakao K, Inoue T, Tokuda M, Sawai K, Hirata M, Funaki T, Watanabe S, Matsuda K, Kato K, Masaki T.
    Ningen Dock 7: 3-7, 2020
  11. Real-world experience of 12-week DAA regimen of glecaprevir and pibrentasvir in patients with chronic HCV infection.
    Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Tanaka Y, Iwakiri K, Kumada T.
    J Gastroenterol Hepatol in press
  12. Immunohistochemically Detected Expression of ATRX, TSC2, and PTEN Predicts Clinical Outcomes in Patients With Grade 1 and 2 Pancreatic Neuroendocrine Tumors.
    Uemura J, Okano K, Oshima M, Suto H, Ando Y, Kumamoto K, Kadota K, Ichihara S, Kokudo Y, Maeba T, Nanno Y, Toyama H, Takada Y, Shimada M, Hanazaki K, Masaki T, Suzuki Y.
    Ann Surg in press
  13. Failure to confirm an SGLT2 inhibitor-induced hematopoietic effect in non-diabetic rats with renal anemia.
    Yamazaki D, Konishi Y, Morikawa T, Kobara H, Masaki T, Hitomi H, Osafune K, Nakano D, Kittikulsuth W, Nishiyama A.
    J Diabetes Investig in press
  14. Clinical outcomes of hepatitis C virus elimination using glecaprevir and pibrentasvir in hemodialysis patients: A multicenter study.
    Morishita A, Ogawa C, Moriya A, Tani J, Yoneyama H, Fujita K, Oryu M, Senoo T, Takaguchi K, Masaki T.
    Hepatol Res in press
  15. Verification of the hormonal and nutritional factors associated with skeletal muscle volume loss in Japanese patients with nonalcoholic fatty liver disease.
    Himoto T, Miyatake K, Maeba T, Masaki T.
    Can J Gastroenterol Hepatol in press
  16. Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic HCV infection in a real-word setting: a large, multicenter study from Japan.
    Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Iwakiri K, Kumada T, Tanaka Y, Okanoue T.
    J Gastroenterol Hepatol in press
  17. Effects of an SGLT2 inhibitor on the salt sensitivity of blood pressure and sympathetic nerve activity in a nondiabetic rat model of chronic kidney disease.
    Wan N, Fujisawa Y, Kobara H, Masaki T, Nakano D, Rahman A, Nishiyama A.
    Hypertens Res in press
  18. Novel endoscopic ligation with O-ring closure involving muscle layer of a gastric artificial defect.
    Nishiyama N, Kobara H, Kobayashi N, Chiyo T, Fujihara S, Yachida T, Masaki T.
    Endoscopy in press
  19. Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis.
    Shi T, Fujita K, Gong J, Nakahara M, Iwama H, Liu S, Yoneyama H, Morishita A, Nomura T, Tani J, Takuma K, Tadokoro T, Himoto T, Oura K, Tsutsui K, Kobara H, Masaki T.
    Oncol Rep in press
  20. Over-the-scope clip -associated complication: development of pocket of abdominal cavity following treatment of colonic diverticula.
    Fujihara S, Kobara H, Nishiyama N, Masaki T.
    Dig Liver Dis in press
  21. Rebleeding after placing over-the-scope clips: rare complication of prophylactic closure after gastric endoscopic submucosal dissection.
    Fujihara S, Kobara H, Nishiyama N, More H, Masaki T.
    JGH Open in press

脳神経内科 英文

  1. Biallelic mutation of HSD17B4 induces middle age-onset spinocerebellar ataxia.
    Matsuda Y, Morino H, Miyamoto R, Kurashige T, Kume K, Mizuno N, Kanaya Y, Tada Y, Ohsawa R, Yokota K, Shimozawa N, Maruyama H, Kawakami H.
    Neurol Genet 6(1): e396, 2020
  2. Retinitis Pigmentosa Prior to Familial ALS Caused by a Homozygous Cilia and Flagella-Associated Protein 410 Mutation.
    Kurashige T, Morino H, Matsuda Y, Mukai T, Murao T, Toko M, Kume K, Ohsawa R, Torii T, Tokinobu H, Maruyama H, Kawakami H.
    J Neurol Neurosurg Psychiatry 91(2): 220-222, 2020
  3. Middle-age-onset Cerebellar Ataxia Caused by a Homozygous TWNK Variant: A Case Report.
    Kume K, Morino H, Miyamoto R, Matsuda Y, Ohsawa R, Kanaya Y, Tada Y, Kurashige T, Kawakami H.
    BMC Med Genet 21(1):68, 2020
  4. Light exercise without lactate elevation induces ischemic tolerance through the modulation of microRNA in the gerbil hippocampus.
    Takata T, Nonaka W, Iwama H, Kobara H, Deguchi K, Masugata H, Touge T, Miyamoto O, Nakamura T, Itano T, Masaki T.
    Brain Res 1732: 146710, 2020
  5. Genetic Screening for Potassium Channel Mutations in Japanese Autosomal Dominant Spinocerebellar Ataxia.
    Tada Y, Kume K, Matsuda Y, Kurashige T, Kanaya Y, Ohsawa R, Morino H, Tabu H, Kaneko S, Suenaga T, Kakizuka A, Kawakami H.
    J Hum Genet 65 (4): 363-369, 2020
  6. Optineurin Regulates Osteoblastogenesis Through STAT1.
    Mizuno N, Iwata T, Ohsawa R, Ouhara K, Matsuda S, Kajiya M, Matsuda Y, Kume K, Tada Y, Morino H, Yoshimoto T, Ueki Y, Mihara K, Sotomaru Y, Takeda K, Munenaga S, Fujita T, Kawaguchi H, Shiba H, Kawakami H, Kurihara H.
    Biochem Biophys Res Commun 525(4): 889-894, 2020

和文

  1. 新たな免疫チェックポイント分子
    藤田浩二、正木 勉
    肝臓 61(3): 101-103, 2020
  2. 多系統萎縮症における自律神経障害
    出口一志
    自律神経 in press

学会

国内学会

  1. パネルディスカッション3 小児の上部消化管疾患の特徴
    地方の大学病院小児科における小児上部消化管内視鏡検査・治療の現状
    近藤園子、小原英幹、近藤健夫、岡田 仁、田中 彩、下野隆一、西山典子、日下 隆
    第16回日本消化管学会総会学術集会 2020.2.7-8, 姫路市
  2. ワークショップ12 食道胃接合部疾患の研究と診療の進歩
    食道扁平上皮癌・腺癌に対するガレクチン- 9の抗腫瘍効果のin vitro、in vivoでの検討
    千代大翔、明石瑛美子、藤田浩二、中谷夏帆、小塚和博、藤森絢子、松井崇矩、合田康宏、小林伸也、西山典子、藤原新太郎、谷内田達夫、森下朝洋、小原英幹、森 宏仁、正木 勉
    第16回日本消化管学会総会学術集会 2020.2.7-8, 姫路市
  3. ワークショップ8 大腸腫瘍診療の最前線:新しい診断・治療法をめざして
    大腸ESD後偶発症予防としての創面縫縮の意義:縫縮群と非縫縮群の比較検討
    小塚和博、谷内田達夫、中谷夏帆、藤森絢子、松井崇矩、合田康宏、千代大翔、小林伸也、西山典子、小原英幹、正木 勉
    第16回日本消化管学会総会学術集会 2020.2.7-8, 姫路市
  4. ワークショップ11 あたらしい内視鏡診断、治療法をめざして -腫瘍性疾患、機能性疾患を含め-
    直腸NETを対象とした切開併用OTSCによる内視鏡的全層切除術の開発
    西山典子、小原英幹、小塚和博、多田尚哉、千代大翔、小林伸也、谷内田達夫、森 宏仁、正木 勉
    第16回日本消化管学会総会学術集会 2020.2.7-8, 姫路市
  5. ワークショップ5 高齢者の消化管出血の最近の傾向と対策
    高齢者の消化管出血に対するOver-The-Scope Clip systemの有用性と選択時期の検討
    多田尚矢、小原英幹、小林伸也、西山典子、小塚和博、千代大翔、谷内田達夫、中林良太、出口章広、正木 勉
    第16回日本消化管学会総会学術集会 2020.2.7-8, 姫路市

地方会

  1. 健常高齢者に発症したクリプトコッカス髄膜炎の一剖検例
    紀乃正志、城 妃咲、土居智和、高田忠幸、羽場礼次、宮井由美、鎌田正紀、出口一志、峠 哲男、正木 勉
    第31回日本老年医学会四国地方会 2020.2.23, 松山市